BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / Felix Baker / Julian Baker

Insider

Director, 10% Owner

Trades at: ACAD

30D 90D 1Y

Net shares · 90d

+2.2M

2.3M buy · 5.5K sell

Net value · 90d

$9.9M

$10.0M in · $131.0K out

Sentiment · 90d

Net buying

99% buying · 1% selling

Open-market trades · 90d

2.3M buy · 5.5K sell

Net buy / sell volume (all companies)

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions · open-market

Include grants & non-market

ACAD Sell·S
May 22, 26

Director

$65.6K

2.8K sh · $23.79

Own -2%
ACAD Sell·S
May 22, 26

Director

$65.4K

2.7K sh · $23.85

Own -2%
ACAD Buy·P
Apr 21, 26

Director, 10% Owner

$9.5M

2.1M sh · $4.44

Own +12%
ACAD Buy·P
Apr 21, 26

Director, 10% Owner

$508.8K

114.6K sh · $4.44

Own +7%

Date▾	Ticker	Role	Type	Shares	Own Δ	Price	Value
May 22, 2026	ACAD	Director	Sell S	2.8K	-2%	$23.79	$65.6K
May 22, 2026	ACAD	Director	Sell S	2.7K	-2%	$23.85	$65.4K
Apr 21, 2026	ACAD	Director, 10% Owner	Buy P	2.1M	+12%	$4.44	$9.5M
Apr 21, 2026	ACAD	Director, 10% Owner	Buy P	114.6K	+7%	$4.44	$508.8K

About BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / Felix Baker / Julian Baker

This profile aggregates every SEC Form 4 insider transaction reported by BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / Felix Baker / Julian Baker across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.